Literature DB >> 11404616

Expression patterns of cytokeratins in retraction pocket cholesteatomas.

H J Kim1, S P Tinling, R A Chole.   

Abstract

OBJECTIVES: To investigate the patterns of cytokeratin (CK) expression in retraction pocket cholesteatoma. STUDY
DESIGN: An animal model study.
METHODS: Retraction pocket cholesteatomas were induced by electrocautery of the eustachian tube orifice in 24 mongolian gerbils. They were divided into normal and cholesteatoma groups of clinical stages I to IV. The antibodies to pan-cytokeratin CK 1/10, CK 5/6, CK 4, and CK 13/16 were used for immunohistochemical staining. The intensity of staining in each group as measured with densitometry was compared regarding anatomical sites and clinical stages.
RESULTS: In retraction pocket cholesteatoma, CK expression was altered only at focal sites such as the pars tensa of the tympanic membrane. The change of CK expression was observed only at certain stages of cholesteatoma formation. In keratinocytes from cholesteatomas, CK 13/16 was overexpressed compared with control specimens, indicating hyperproliferation. The site with the most prominent change in retraction pocket cholesteatoma was somewhat different from that in canal ligation cholesteatoma in a previous study.
CONCLUSIONS: The results suggested that aural cholesteatoma is a disease with a spectrum of pathological conditions and that the transmigration and hyperproliferation process of squamous epithelium occurs in areas adjacent to the cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404616     DOI: 10.1097/00005537-200106000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Yasuaki Shibata; Haruo Takahashi; Tohru Ikeda; Takehiko Koji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-20       Impact factor: 2.503

Review 2.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

3.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

4.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

Review 5.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.